175 related articles for article (PubMed ID: 11333347)
1. Rheumatoid arthritis.
Gay S
Curr Opin Rheumatol; 2001 May; 13(3):191-2. PubMed ID: 11333347
[No Abstract] [Full Text] [Related]
2. Regulators of cytokine signalling in rheumatoid arthritis.
Rahman A
Rheumatology (Oxford); 2007 Dec; 46(12):1745-6. PubMed ID: 17986480
[No Abstract] [Full Text] [Related]
3. Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis.
Kumar S; Blake SM; Emery JG
Curr Opin Pharmacol; 2001 Jun; 1(3):307-13. PubMed ID: 11712756
[TBL] [Abstract][Full Text] [Related]
4. Targeted drug development for arthritis.
Malemud CJ
Future Med Chem; 2012 Apr; 4(6):701-3. PubMed ID: 22530633
[No Abstract] [Full Text] [Related]
5. Emerging targets of biologic therapies for rheumatoid arthritis.
Tarner IH; Müller-Ladner U; Gay S
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):336-45. PubMed ID: 17538565
[TBL] [Abstract][Full Text] [Related]
6. How antirheumatic drugs protect joints from damage in rheumatoid arthritis.
Schett G; Stach C; Zwerina J; Voll R; Manger B
Arthritis Rheum; 2008 Oct; 58(10):2936-48. PubMed ID: 18821703
[No Abstract] [Full Text] [Related]
7. Current world literature.
Curr Opin Rheumatol; 2010 May; 22(3):348-61. PubMed ID: 20351495
[No Abstract] [Full Text] [Related]
8. Targeting TNF receptors in rheumatoid arthritis.
Blüml S; Scheinecker C; Smolen JS; Redlich K
Int Immunol; 2012 May; 24(5):275-81. PubMed ID: 22457216
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid arthritis.
Ramsburg KL
Am J Nurs; 2000 Nov; 100(11):40-3. PubMed ID: 11103634
[No Abstract] [Full Text] [Related]
10. A new century of antirheumatic therapy.
McMurray RW
Am J Med Sci; 2002 Apr; 323(4):169-70. PubMed ID: 12003370
[No Abstract] [Full Text] [Related]
11. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.
Cutolo M; Sulli A; Pizzorni C; Seriolo B; Straub RH
Ann Rheum Dis; 2001 Aug; 60(8):729-35. PubMed ID: 11454634
[No Abstract] [Full Text] [Related]
12. Cytokine pathways and joint inflammation in rheumatoid arthritis.
Choy EH; Panayi GS
N Engl J Med; 2001 Mar; 344(12):907-16. PubMed ID: 11259725
[No Abstract] [Full Text] [Related]
13. [Adiponectin as target in rheumatoid arthritis].
Neumann E; Frommer KW; Müller-Ladner U
Z Rheumatol; 2014 Aug; 73(6):556-8. PubMed ID: 25037477
[No Abstract] [Full Text] [Related]
14. Apoptosis as a mechanism of action of tumor necrosis factor antagonists in rheumatoid arthritis.
Makrygiannakis D; Catrina AI
J Rheumatol; 2012 Apr; 39(4):679-85. PubMed ID: 22422498
[TBL] [Abstract][Full Text] [Related]
15. Biological agents in rheumatoid arthritis.
Shankar S; Handa R
J Postgrad Med; 2004; 50(4):293-9. PubMed ID: 15623977
[TBL] [Abstract][Full Text] [Related]
16. KCa1.1 channels as therapeutic targets for rheumatoid arthritis.
Beeton C
Expert Opin Ther Targets; 2017 Dec; 21(12):1077-1081. PubMed ID: 29076378
[No Abstract] [Full Text] [Related]
17. One year in review 2016: novelties in the treatment of rheumatoid arthritis.
Calabrò A; Caterino AL; Elefante E; Valentini V; Vitale A; Talarico R; Cantarini L; Frediani B
Clin Exp Rheumatol; 2016; 34(3):357-72. PubMed ID: 27268779
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.
Craig E; Cappelli LC
Rheum Dis Clin North Am; 2018 Feb; 44(1):89-111. PubMed ID: 29149929
[TBL] [Abstract][Full Text] [Related]
19. Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling.
Kyburz D; Brentano F; Gay S
Nat Clin Pract Rheumatol; 2006 Sep; 2(9):458-9. PubMed ID: 16951696
[No Abstract] [Full Text] [Related]
20. The potential role of angiogenic factors in rheumatoid arthritis.
Azizi G; Boghozian R; Mirshafiey A
Int J Rheum Dis; 2014 May; 17(4):369-83. PubMed ID: 24467605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
